NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
Clinical Trials
8 trialsNCT02958852 2025-09-10
ABC-SE
Lund University Hospital
Phase 2 Completed
NCT03872388 2024-10-02
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01988571 2022-01-04
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Wake Forest University Health Sciences
Phase 2 Completed
NCT02674204 2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT02416427 2015-04-15
TRINACRIA
Regina Elena Cancer Institute
Phase 2 Unknown
NCT00816244 2012-04-13
Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer
Lund University Hospital
Phase 2 Completed
NCT00914017 2010-02-11
Statins and Breast Cancer Biomarkers
University of Vermont
Phase 2 Unknown